Oncolytics Biotech Inc.
ONCY
$0.80
-$0.01-1.24%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 8.20% | -27.89% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.06% | -0.90% | |||
| Operating Income | -1.06% | 0.90% | |||
| Income Before Tax | -1.06% | -6.46% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.15% | -4.05% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.15% | -4.05% | |||
| EBIT | -1.06% | 0.90% | |||
| EBITDA | -1.07% | 0.90% | |||
| EPS Basic | 4.13% | 1.56% | |||
| Normalized Basic EPS | 5.06% | -0.78% | |||
| EPS Diluted | 4.13% | 1.56% | |||
| Normalized Diluted EPS | 5.06% | -0.78% | |||
| Average Basic Shares Outstanding | 6.63% | 5.64% | |||
| Average Diluted Shares Outstanding | 6.63% | 5.64% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||